Impact BioMedical Inc. (IBO:NYSEMKT) closed at $3.06 on October 19, 2026, up 14.18% on the day. The stock trades 70.9% below its 52-week high of $10.51 and 25.9% above its 52-week low of $2.43. Impact BioMedical Inc. is part of the Health Care sector.
| 5D | 1M | 3M | 6M |
|---|---|---|---|
| -33.50% | -62.92% | -52.42% | -68.86% |
In 251 trading sessions since October 16, 2025, IBO closed higher on 101 days (40%). Its best day was March 20, 2026 (+68.47%) and its worst was March 13, 2026 (-18.75%). The stock moved 10% or more in a single session 13 times. It opened at least 5% above the previous day's high 3 times.
Impact BioMedical Inc. engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. It provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. The company also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, it develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use in as health supplements and medications.
Find more stocks like IBO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.